UBRO RED DRY COW INTRAMAMMARY SUSPENSION
Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
Summary of Product characteristics
(SPC)
24-09-2015
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
PENETHAMATE HYDRIODIDE, PROCAINE BENZYLPENICILLIN, FRAMYCETIN SULFATE
Available from:
Boehringer Ingelheim Ltd
ATC code:
QJ51RC
INN (International Name):
PENETHAMATE HYDRIODIDE, PROCAINE BENZYLPENICILLIN, FRAMYCETIN SULFATE
Dosage:
Unknown
Pharmaceutical form:
intramammary Suspension
Prescription type:
POM
Therapeutic group:
Bovine
Therapeutic area:
Beta-lactam antibacterials, penicillins, combinations with other antibacterials
Therapeutic indications:
Antibacterial
Authorization status:
Authorised
Authorization date:
2006-02-10
Summary of Product characteristics
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Ubro Red Dry Cow Intramammary Suspension
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
3 PHARMACEUTICAL FORM
Intramammary suspension.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Bovine
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For routine use in cows to treat existing intramammary infections at drying off and to assist in preventing new
infections occurring during the dry period.
_In vitro _efficacy has been demonstrated against the following organisms:
Staphylococcus spp.
Streptococcus spp.
Cornynebacteria spp.
_Escherichia coli_
Klebsiella spp.
Pseudomonas spp.
4.3 CONTRAINDICATIONS
Do not administer to animals with known sensitivity to the active ingredients.
Do not use in the lactating cow.
Not intended for use within 28 days of calving.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
Where there is a risk of summer mastitis, additional management procedures, such as fly control, should be considered.
Each 5ml dose unit contains the following active ingredients:
Penethamate Hydriodide
100.0 mg
Procaine Benzylpenicillin
300.0 mg
Framycetin Sulphate
100.0 mg
For a full list of excipients, see section 6.1
HEALTH PRODUCTS REGULATORY AUTHORITY
________________________________________________________________________________________________________________________
_Date Printed 09/09/2015_
_CRN 7021615_
_page number: 1_
4.5 SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
Before infusion, the teats should be thoroughly cleansed and disinfected and care should be taken to avoid
contamination of the injector nozzle.
Following infusion it is advisable to use a teat dip or spray.
SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE VETERINARY MEDICINAL PRODUCT TO ANIMALS
Penicillin and cephalosporins may cause hyp
Read the complete document
